Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Pharmaceuticals
INVESTING
Sage Therapeutics Rises After Swing to Profit on Biogen Deal
By Vidhi Choudhary
INVESTING
Johnson & Johnson COVID Vaccine Gets FDA Support Before Emergency Use Hearing
By Martin Baccardax
INVESTING
ICON to Buy PRA Health in $12 Billion Cash-and-Stock Deal
By M. Corey Goldman
INVESTING
Celsion Surges as FDA Fast-Tracks Ovarian-Cancer Drug
By Dan Weil
INVESTING
GlaxoSmithKline and Sanofi Re-Start COVID Vaccine Trials
By Martin Baccardax
LATEST NEWS
Giving Pfizer a Shot: Virologist Gives His Take on the Jab in Japan
By Adam Smith
LATEST NEWS
COVID on Track to Kill a Half Million Americans
By Adam Smith
LATEST NEWS
Will Pfizer Shots Be the Ticket to the Tokyo Olympics?
By Adam Smith
INVESTING
Vaccinex Spikes on Deals with Two Pharma Companies
By Vidhi Choudhary
INVESTING
Pfizer Seeks FDA Approval For Higher Coronavirus Vaccine Storage Temperatures
By Martin Baccardax
INVESTING
Invitae Lifted to Buy on Growth Potential and Cost Controls
By Rob Lenihan
INVESTING
Immunome Skyrockets on Isolation of COVID Antibodies
By Dan Weil
INVESTING
Rigel Pharmaceuticals Rises on Drug Venture With Eli Lilly
By Dan Weil
INVESTING
Vir Biotech Jumps on New Drug Development Deal With GSK
By Dan Weil
INVESTING
Moderna Receives FDA Nod to Add More Vaccine to Vials: Report
By Dan Weil
INVESTING
5 Top Stock Gainers for Friday: Fisker, HubSpot, Illumina
By Rob Lenihan
Video
The Pot Stock Outlook is Hazy - Here's the Lowdown
INVESTING
Pot Stocks Stay Volatile - Here’s What’s Happening Friday
By M. Corey Goldman
INVESTING
Teva's Fourth-Quarter Adjusted Earnings Top Forecasts
By Dan Weil
INVESTING
Veru Leaps on Progress With COVID-19 Treatment Trial
By Rob Lenihan
INVESTING
Heat Biologics Jumps on Progress With Lung-Cancer Drug
By Tony Owusu
INVESTING
KalVista Reports Positive Test Results for Angioedema Drug; Shares Soar
By Dan Weil
INVESTING
Eli Lilly CFO Smiley Resigns Over 'Inappropriate Relationship'
By Rob Lenihan
INVESTING
Eye-Drug Firm Ocugen Triples After Direct Offering
By Dan Weil